AusPAR: Nivolumab and ipilimumab
Australian Public Assessment Report
Device/Product Name
Opdivo and Yervoy/Winglore
Active ingredients
Nivolumab and ipilimumab
AusPAR Date
Published
Submission Number
PM-2018-02005-1-4 and PM-2018-02012-1-4
Submission Type
Extension of indication
Decision
Withdrawn